From expanding laboratories across the country, exporting diagnostic kits, conducting four rounds of nationwide serosurvey to indigenous vaccine development covaxin Dr Balram Bhargava, Director, Indian Council of Medical Research said during its launch that while proving its effectiveness against multiple variants of the SARS-CoV2 virus, India has shown that it is not only a vaccine manufacturing superpower, but also a developer of vaccines. Is. book
Covaxin’s Viral-Inside Story on Thursday.
Dr Bhargava made a presentation on the occasion and said that this was the biggest and fastest vaccine campaign.
“This story is an example for the Global South, where testing was scaled up in record time, with a vaccine deployed in 10 months and 100 million doses delivered in record time,” he said.
More than 50 percent vaccination has been done in rural areas and more than 48 percent women in the country have been vaccinated.
More than 75 percent of the adult population has been vaccinated with a single dose and more than 35 percent have been fully vaccinated.
.